Subclinical infection as a cause of inflammation in preeclampsia

American Journal of Therapeutics

Volumn 15, Issue 4, 2008, Pages 373-376

  López Jaramillo, Patricio ^a,b,d   Herrera, Julian A ^c   Arenas Mantilla, Mario ^a   Jáuregui, Isabel E ^a   Mendoza, Mayaris A ^a  

^a Vilano Group   (Colombia)

^b UNIVERSIDAD DE SANTANDER   (Colombia)

^c UNIVERSIDAD DEL VALLE   (Colombia)

^d FUNDACIÓN CARDIOVASCULAR DE COLOMBIA   (Colombia)

Author keywords

Endothelium; Infection; Inflammation; Nitric oxide; Preeclampsia

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

ARTICLE; DEVELOPED COUNTRY; DISEASE PREDISPOSITION; ENDOTHELIAL DYSFUNCTION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MICROORGANISM; PATHOGENESIS; PERIODONTAL DISEASE; PREECLAMPSIA; PRENATAL CARE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SOUTH AND CENTRAL AMERICA; URINARY TRACT INFECTION; VAGINITIS; WEIGHT GAIN; BACTERIAL INFECTION; FEMALE; METABOLISM; METHODOLOGY; MICROBIOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; VASCULAR ENDOTHELIUM;

BACTERIAL INFECTIONS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; LATIN AMERICA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; RISK FACTORS;

EID: 51649104762     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e318164c149     Document Type: Article

References (34)

1. Walker JJ: Pre-eclampsia. Lancet. 2000;356:1260-1265.
2. Maternal Mortality in 2000: Estimates Developed by WHO, UNICEF and UNFPA. Geneva: World Health Organization, 2004.
3. López-Jaramillo P. Calcium, nitric oxide, and preeclampsia. Sem Perinatol. 2000;24:33-36.
4. López-Jaramillo P, Casas JP, Serrano NC. Preeclampsia: from epidemiological observations to molecular mechanisms. Braz J Med Biol Res. 2001;34:1227-1235.
5. López-Jaramillo P, Garcia RG, López M. Preventing pregnancy-induced hypertension: are there regional differences for this global problem? J Hypertens. 2005;23: 1121-1129.
6. Technical Report Series. The Hypertensive Disorders of Pregnancy. Geneva: WHO, 1987.
7. Kupferminc MJ, Peaceman AM, Wington TR, et al. Inmunoreactive tumor necrosis factor-α is elevated in maternal plasma but undetected in amniotic fluid in the second trimester. Am J Obstet Gynecol. 1994;171:976-979.
8. Redman C, Sacks G, Sargent I. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1990;180:499-506.
9. López-Jaramillo P, Escudero C, Moya W. Markers of systemic inflammation and nitric oxide metabolites in preeclampsia. Nitric Oxide Biol Chem. 1998;2:127.
10. Vince GS, Starkey PM, Austgulen R. Interleukin-6, tumor necrosis factor and soluble receptors in women with preeclampsia. Br J Obstet Gynaecol. 1995;102:20-25.
11. Hamai Y, Fujii T, Yamashita T, et al. Evidence for elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Inmunol. 1997;38:89-93.
12. Kupferminc MJ, Peaceman AM, Aderka D, et al. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol. 1996; 88:420-427.
13. Teran E, Escudero C, Moya W, et al. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia. Int J Gynecol Obstet. 2001;75: 243-249.
14. Greer IA, Lyall F, Perera T, et al. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol. 1994;84:937-940.
15. Hill JA, Devoe L, Bryans C. Frequency of asymptomatic bacteriuria in preeclampsia. Obstet Gynecol. 1986;67: 529-532.
16. Abi Said D, Annegers JF, Combs-Cantrell D, et al. Case-control study of the risk factors for preeclampsia. Am J Epidemiol. 1995;142:437-441.
17. Hsu CD, Witter FR. Urogenital infection in preeclampsia. Int J Gynecol Obstet. 1995;49:271-275.
18. Mittendorf R, Lain KY, Williams MA, et al. Preeclampsia. A nested, case-control study for risk factors and their interactions. J Reprod Med. 1996;41:491-496.
19. Herrera JA, Chaudhuri G, López-Jaramillo P. Is infection a major risk factor for preeclampsia? Med Hypotheses. 2001;57:393-397.
20. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol. 1993;169: 1316-1320.
21. Moncada S, Higgs EA, Hodson HF, et al. The L-arginine: nitric oxide pathway. J Cardiovasc Pharmacol. 1991; 17(Suppl 3):S1-S9.
22. Davidge ST. Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reprod Endocrinol. 1998; 16:65-73.
23. Belayet HM, Kanayama N, Kathun S, et al. Decreased renal and hepatic blood flow with preeclampsia-like histologic changes was obtained by stimulation of the celiac ganglion with LPS. Am J Perinatol. 1998;15:109-114.
24. Herrera JA, Shahabuddin AK, Ersheng G, et al. Calcium plus linoleic acid therapy for pregnancy-induced hypertension. Int J Gynecol Obstet. 2005;91:221-227.
25. Herrera JA, Arevalo-Herrera M, Shahabuddin AK, et al. Calcium and conjugated linoleic acid reduces pregnancy-induced hypertension and decreases intracellular calcium in lymphocytes. Am J Hypertens. 2006;19:381-387.
26. Sierra-Laguado J, García RG, López-Jaramillo P. Flow-mediated dilation of the brachial artery in pregnancy. Int J Gynecol Obstet. 2006;93:60-61.
27. Accini JL, Sotomayor A, Trujillo F, et al. Colombian study to assess the use of noninvasive determination of endothelium-mediated vasodilatation (CANDEV). Normal values and factors associated. Endothelium. 2001;8: 157-166.
28. García RG, Celedón J, Sierra-Laguado J, et al. Raised C-reactive protein and impaired flow mediated vasodilation precede the development of preeclampsia. Am J Hypertens. 2007;20:437-442.
29. Offenbacher S, Katz V, Fertik G, et al. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol. 1996;67:1103-1113.
30. Boggess KA, Lieff S, Murtha AP, et al. Maternal periodontal disease is associated with an increased risk for preeclampsia. Obstet Gynecol. 2003;101:227-231.
31. Canakci V, Canakci CF, Canakci H, et al. Periodontal disease as a risk factor for pre-eclampsia: a case control study. Aust N Z J Obstet Gynaecol. 2004;44:568-573.
32. Contreras A, Herrera JA, Soto JE, et al. Periodontitis is associated with preeclampsia in pregnant women. J Periodontol. 2006;77:182-188.
33. Haraszthy VI, Zambon JJ, Trevisan M, et al. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000;71:1554-1560.
34. Herrera JA, Parra B, Herrera E, et al. Periodontal disease severity is related to high levels of C-reactive protein in preeclampsia. J Hypertens. 2007;25:1459-1464.